Skip to main content

Table 3 Summary of univariate/multivariate analysis for overall survival in patients with NSCLC (n = 350)

From: Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer

Variables Univariate analysis Multivariate analysis
Average survival time (SE) 95%CI P-value Exp (B) 95.0%CI P-value
p-S6
 High expression 44.561 (3.050) 38.583-50.540 0.013* 1.549 1.105-2.173 0.011*
 Low expression 67.500 (5.336) 57.041-77.958     
Clinical stages
 Stage I-II 68.200 (4.195) 59.977-76.423 0.000* 1.980 1.356-2.893 0.000*
 Stage III 47.862 (3.834) 40.347-55.378     
LN status
 LNM 44.969 (3.201) 38.695-51.243 0.000* 1.609 1.098-2.360 0.015*
 No LNM 74.932 (5.919) 63.330-86.533     
Histological type
 SCC 63.464 (5.825) 52.046-74.882 0.240 1.137 0.806-1.603 0.464
 ADC 50.588 (3.367) 43.988-57.188     
Pathological grade
 Well/moderated 58.662 (3.509) 51.784-65.541 0.003* 1.517 1.094-2.104 0.013*
 Poor 54.226 (4.164) 46.066-62.387     
Age
  ≤ 50 45.395 (3.633) 38.274-52.515 0.454 1.014 0.718-1.430 0.939
 >50 61.199 (4.064) 53.234-69.165     
Gender
 Female 54.566 (4.467) 45.810-63.321 0.210 0.718 0.484-1.064 0.099
 Male 57.363 (3.886) 49.747-64.978     
  1. Abbreviations: CI Confidence interval, Exp(B) Odds ratio, SE Standard error, LNM Lymph node metastasis;
  2. * P < 0.05